A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation
Jiahao Wu(Northern Jiangsu People's Hospital), Guangbo Kang(Tianjin University of Technology), Mengxue Gao(Anhui Agricultural University), Shaolan Zou(Tianjin University), He Huang(Renmin University of China), Lina Wang(Tianjin University), Zhixin Zhu(Tianjin University of Science and Technology), Bing‐Zhi Li(Tianjin University), Shuxian Meng(Tianjin University), Yuanhang Feng(Tianjin University), Xiaocang Cao(Tianjin Medical University General Hospital)
Cited by 35
Related Papers
Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice
|Cell|2024|253
Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice
|Nature Microbiology|2024|118
Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment
|Frontiers in Immunology|2022|84
Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice
|Microbial Cell Factories|2020|69